Eterna Therapeutics
ERNA • NASDAQ
Eterna Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanjeev Luther, with a market cap of $5.3M.
CEOSanjeev Luther
Market Cap$5.3M
Biotechnology
Healthcare
Employees8.0
Websiteeternatx.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Eterna Therapeutics
Date
Wednesday, May 6, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Eterna Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 2025 | Q3 2025 | -$0.15 | — | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.61 | — | - | — | 10-Q |
| May 7, 2025 | Q4 2024 | -$0.15 | — | - | — | — |
| Nov 12, 2024 | Q3 2024 | -$4.92 | — | $487.0K | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$1.02 | — | $47.0K | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$1.23 | — | $47.0K | — | 10-Q |
| Mar 14, 2024 | Q4 2023 | -$1.14 | — | $17.0K | — | 10-K/A |
| Nov 13, 2023 | Q3 2023 | -$1.03 | — | $51.0K | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.85 | — | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$1.06 | — | - | — | — |
| Mar 20, 2023 | Q4 2022 | -$1.24 | — | - | — | — |
| Nov 14, 2022 | Q3 2022 | -$2.49 | — | - | — | — |